Drug
GF 001001 00
GF 001001 00: highest development phase Phase 2, developed by Ferrer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| GF-001001-00 NCT01005771 | Phase 2 | Secondarily Infected Traumatic Lesions |
Latest
No recent events.
Follow GF 001001 00 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.